PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2019; 10(04): 206-209
DOI: 10.1055/s-0040-1709277
Original Article

Natural History of Patients with Unresectable Cholangiocarcinoma

Sudhakar A.
1   Department of Gastroenterology, KGH, Visakhapatnam, Andhra Pradesh, India
,
Sravan Kumar K.
1   Department of Gastroenterology, KGH, Visakhapatnam, Andhra Pradesh, India
,
L. R.S. Girinadh
1   Department of Gastroenterology, KGH, Visakhapatnam, Andhra Pradesh, India
,
P. MuraliKrishna
1   Department of Gastroenterology, KGH, Visakhapatnam, Andhra Pradesh, India
› Institutsangaben Financial support No.
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Cholangiocarcinoma is a malignancy of the bile ducts. Globally, CCA is the second most common primary hepatic malignancy. These tumors usually progress insidiously, are difficult to diagnose, and have poor prognosis. Unfortunately, treatment options are discouraging. Data on the natural history of CCA in coastal Andhra Pradesh is limited. Our aim is to report the natural history of CCA in this region.

Key words

cholangiocarcinoma - jaundice - survival - biliary drainage


Publikationsverlauf

Artikel online veröffentlicht:
04. Mai 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24 (02) 115-125
    Thieme ConnectPubMedSuche in Google Scholar
  • 2 Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33 (06) 1353-1357
    CrossrefPubMedSuche in Google Scholar
  • 3 Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005; 128 (03) 620-626
    CrossrefPubMedSuche in Google Scholar
  • 4 Gores GJ. A spotlight on cholangiocarcinoma. Gastroenterology 2003; 125 (05) 1536-1538
    CrossrefPubMedSuche in Google Scholar
  • 5 Gores GJ. Cholangiocarcinoma: current concepts and insights. Hepatology 2003; 37 (05) 961-969
    CrossrefPubMedSuche in Google Scholar
  • 6 Weber A, Landrock S, Schneider J. et al. Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma. World J Gastroenterol 2007; 13 (09) 1422-1426
    CrossrefPubMedSuche in Google Scholar
  • 7 Lang H, Sotiropoulos GC, Frühauf NR. et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 2005; 241 (01) 134-143
    CrossrefPubMedSuche in Google Scholar
  • 8 Witzigmann H, Berr F, Ringel U. et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 2006; 244 (02) 230-239
    CrossrefPubMedSuche in Google Scholar